HomePHARMA • KLSE
Pharmaniaga Berhad
RM 0.34
May 6, 5:31:23 PM GMT+8 · MYR · KLSE · Disclaimer
StockMY listed security
Previous close
RM 0.35
Day range
RM 0.34 - RM 0.35
Year range
RM 0.30 - RM 0.51
Market cap
482.81M MYR
Avg Volume
880.38K
P/E ratio
-
Dividend yield
-
Primary exchange
KLSE
Market news
Financials
Income Statement
Revenue
Net income
(MYR)Dec 2023Y/Y change
Revenue
789.81M-8.45%
Operating expense
13.71M-86.15%
Net income
-32.72M94.92%
Net profit margin
-4.1494.46%
Earnings per share
EBITDA
3.53M100.61%
Effective tax rate
-45.16%
Total assets
Total liabilities
(MYR)Dec 2023Y/Y change
Cash and short-term investments
127.44M123.74%
Total assets
1.90B4.59%
Total liabilities
2.17B6.23%
Total equity
-271.38M
Shares outstanding
1.37B
Price to book
-1.59
Return on assets
-0.94%
Return on capital
-2.00%
Net change in cash
(MYR)Dec 2023Y/Y change
Net income
-32.72M94.92%
Cash from operations
30.57M201.60%
Cash from investing
-25.09M-19.57%
Cash from financing
91.37M19.49%
Net change in cash
96.72M290.29%
Free cash flow
57.46M-68.29%
About
Pharmaniaga Berhad is a Malaysian pharmaceutical company. It is a subsidiary of Boustead Holdings, an affiliate of the Malaysian military. Wikipedia
Founded
1994
Employees
3,778
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu